trial summary · NCT07413744
The Gut - PRO Study
Probiotic Supplementation Safety and Feasibility Study in Preclinical Alzheimer's Disease
Trial record from the TrialBase DB dataset, status RECRUITING, condition Alzheimer Disease, sponsored by University of Wisconsin, Madison. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The purpose of this study is to assess the safety and feasibility of an oral probiotic supplement (PS) intervention in individuals with dementia or mild-cognitive impairment (MCI) due to Alzheimer's disease or at risk of dementia due to Alzheimer's disease (AD). 40 participants will be enrolled and can expect to be on study for up to 1 year.
Source record: https://clinicaltrials.gov/study/NCT07413744
Facts
| registry id | NCT07413744 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE1 |
| study type | INTERVENTIONAL |
| lead condition | Alzheimer Disease |
| sponsor | University of Wisconsin, Madison |
| sponsor class | OTHER |
| enrollment | 40 |
| start date | 2026-11 |
| primary completion | 2029-09 |
| completion | 2029-09 |
| results posted | not reported |
Conditions
- Alzheimer Disease
Interventions
- Probiotic
- Placebo
Countries
- United States
Intervention types: DRUG, OTHER
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.